Verition Fund Management LLC Intercept Pharmaceuticals, Inc. Put Options Transaction History

Verition Fund Management LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2021 Aug 16, 2021	SELL	$15.46 - $24.5 $1.9 Million - $3 Million	-122,600 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$19.33 - $37.75 $1.9 Million - $3.72 Million	98,500 Added 408.71%	122,600 $2.83 Million
Q4 2020 Feb 16, 2021	SELL	$24.48 - $42.47 $257,040 - $445,935	-10,500 Reduced 30.35%	24,100 $595,000
Q3 2020 Nov 16, 2020	BUY	$39.09 - $53.44 $1.18 Million - $1.61 Million	30,200 Added 686.36%	34,600 $1.44 Million
Q2 2020 Aug 14, 2020	BUY	$46.7 - $92.04 $205,480 - $404,976	4,400 New	4,400 $211,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.